Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Dec;31(12):1961–1966. doi: 10.1128/aac.31.12.1961

A40926, a new glycopeptide antibiotic with anti-Neisseria activity.

B P Goldstein 1, E Selva 1, L Gastaldo 1, M Berti 1, R Pallanza 1, F Ripamonti 1, P Ferrari 1, M Denaro 1, V Arioli 1, G Cassani 1
PMCID: PMC175835  PMID: 2964225

Abstract

In the course of a search for glycopeptide antibiotics having novel biological properties, we isolated A40926. Produced by an actinomycete of the genus Actinomadura, A40926 is a complex of four main factors which contain a fatty acid as part of a glycolipid attached to the peptide backbone. Its activity was, in most respects, similar to that of other glycopeptides, such as vancomycin and teicoplanin. However, in addition to inhibiting gram-positive bacteria, A40926 was very active against Neisseria gonorrhoeae. A40926 was rapidly bactericidal for N. gonorrhoeae clinical isolates at concentrations equal to or slightly higher than the MIC. In mice, levels in serum were higher and more prolonged than those of an equivalent subcutaneous dose of teicoplanin. These properties suggest that A40926 may have potential in the therapy of gonorrhea.

Full text

PDF
1961

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arioli V., Pallanza R., Furesz S., Carniti G. Rifampicin: a new rifamycin. I. Bacteriological studies. Arzneimittelforschung. 1967 May;17(5):523–529. [PubMed] [Google Scholar]
  2. Arioli V., Pallanza R. Teicoplanin-resistant coagulase-negative staphylococci. Lancet. 1987 Jan 3;1(8523):39–39. doi: 10.1016/s0140-6736(87)90724-0. [DOI] [PubMed] [Google Scholar]
  3. Boeck L. D., Mertz F. P. A47934, a novel glycopeptide-aglycone antibiotic produced by a strain of Streptomyces toyocaensis taxonomy and fermentation studies. J Antibiot (Tokyo) 1986 Nov;39(11):1533–1540. doi: 10.7164/antibiotics.39.1533. [DOI] [PubMed] [Google Scholar]
  4. Boslego J. W., Tramont E. C., Takafuji E. T., Diniega B. M., Mitchell B. S., Small J. W., Khan W. N., Stein D. C. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1987 Jul 30;317(5):272–278. doi: 10.1056/NEJM198707303170504. [DOI] [PubMed] [Google Scholar]
  5. Eggert J. H., Michel K. H. Isolation and characterization of A41030, a complex of novel glycopeptide antibiotics. Application of the Michel-Miller high performance low pressure liquid chromatography system. J Antibiot (Tokyo) 1986 Jun;39(6):792–799. doi: 10.7164/antibiotics.39.792. [DOI] [PubMed] [Google Scholar]
  6. Folena-Wasserman G., Poehland B. L., Yeung E. W., Staiger D., Killmer L. B., Snader K., Dingerdissen J. J., Jeffs P. W. Kibdelins (AAD-609), novel glycopeptide antibiotics. II. Isolation, purification and structure. J Antibiot (Tokyo) 1986 Oct;39(10):1395–1406. doi: 10.7164/antibiotics.39.1395. [DOI] [PubMed] [Google Scholar]
  7. Glupczynski Y., Lagast H., Van der Auwera P., Thys J. P., Crokaert F., Yourassowsky E., Meunier-Carpentier F., Klastersky J., Kains J. P., Serruys-Schoutens E. Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. Antimicrob Agents Chemother. 1986 Jan;29(1):52–57. doi: 10.1128/aac.29.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grappel S. F., Giovenella A. J., Phillips L., Pitkin D. H., Nisbet L. J. Antimicrobial activity of aridicins, novel glycopeptide antibiotics with high and prolonged levels in blood. Antimicrob Agents Chemother. 1985 Nov;28(5):660–662. doi: 10.1128/aac.28.5.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kawamoto I., Oka T., Nara T. Cell wall composition of Micromonospora olivoasterospora, Micromonospora sagamiensis, and related organisms. J Bacteriol. 1981 May;146(2):527–534. doi: 10.1128/jb.146.2.527-534.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kucers A. Vancomycin. J Antimicrob Chemother. 1984 Dec;14(6):564–567. [PubMed] [Google Scholar]
  11. Lechevalier M. P. Identification of aerobic actinomycetes of clinical importance. J Lab Clin Med. 1968 Jun;71(6):934–944. [PubMed] [Google Scholar]
  12. Minnikin D. E., Alshamaony L., Goodfellow M. Differentiation of Mycobacterium, Nocardia, and related taxa by thin-layer chromatographic analysis of whole-organism methanolysates. J Gen Microbiol. 1975 May;88(1):200–204. doi: 10.1099/00221287-88-1-200. [DOI] [PubMed] [Google Scholar]
  13. Nieto M., Perkins H. R. Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin. Biochem J. 1971 Aug;123(5):789–803. doi: 10.1042/bj1230789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rake J. B., Gerber R., Mehta R. J., Newman D. J., Oh Y. K., Phelen C., Shearer M. C., Sitrin R. D., Nisbet L. J. Glycopeptide antibiotics: a mechanism-based screen employing a bacterial cell wall receptor mimetic. J Antibiot (Tokyo) 1986 Jan;39(1):58–67. doi: 10.7164/antibiotics.39.58. [DOI] [PubMed] [Google Scholar]
  15. Rice R. J., Biddle J. W., JeanLouis Y. A., DeWitt W. E., Blount J. H., Morse S. A. Chromosomally mediated resistance in Neisseria gonorrhoeae in the United States: results of surveillance and reporting, 1983-1984. J Infect Dis. 1986 Feb;153(2):340–345. doi: 10.1093/infdis/153.2.340. [DOI] [PubMed] [Google Scholar]
  16. Schwalbe R. S., Stapleton J. T., Gilligan P. H. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987 Apr 9;316(15):927–931. doi: 10.1056/NEJM198704093161507. [DOI] [PubMed] [Google Scholar]
  17. Sitrin R. D., Chan G. W., Dingerdissen J. J., Holl W., Hoover J. R., Valenta J. R., Webb L., Snader K. M. Aridicins, novel glycopeptide antibiotics. II. Isolation and characterization. J Antibiot (Tokyo) 1985 May;38(5):561–571. doi: 10.7164/antibiotics.38.561. [DOI] [PubMed] [Google Scholar]
  18. Spiri-Nakagawa P., Fukushi Y., Maebashi K., Imamura N., Takahashi Y., Tanaka Y., Tanaka H., Omura S. Izupeptins A and B, new glycopeptide antibiotics produced by an actinomycete. J Antibiot (Tokyo) 1986 Dec;39(12):1719–1723. doi: 10.7164/antibiotics.39.1719. [DOI] [PubMed] [Google Scholar]
  19. Staneck J. L., Roberts G. D. Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography. Appl Microbiol. 1974 Aug;28(2):226–231. doi: 10.1128/am.28.2.226-231.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Verbist L., Tjandramaga B., Hendrickx B., Van Hecken A., Van Melle P., Verbesselt R., Verhaegen J., De Schepper P. J. In vitro activity and human pharmacokinetics of teicoplanin. Antimicrob Agents Chemother. 1984 Dec;26(6):881–886. doi: 10.1128/aac.26.6.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Williams A. H., Grüneberg R. N. Teicoplanin. J Antimicrob Chemother. 1984 Nov;14(5):441–445. [PubMed] [Google Scholar]
  22. Williams A. H., Grüneberg R. N., Webster A., Ridgway G. L. Teicoplanin in the treatment of infection caused by gram-positive organisms. J Hosp Infect. 1986 Mar;7 (Suppl A):101–103. doi: 10.1016/0195-6701(86)90014-9. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES